213 related articles for article (PubMed ID: 9643563)
1. Parathyroid hormone-related protein in hypercalcemia associated with hematological malignancy.
Firkin F; Schneider H; Grill V
Leuk Lymphoma; 1998 May; 29(5-6):499-506. PubMed ID: 9643563
[TBL] [Abstract][Full Text] [Related]
2. Hypercalcemia of malignancy: the central role of parathyroid hormone-related protein.
Wysolmerski JJ; Broadus AE
Annu Rev Med; 1994; 45():189-200. PubMed ID: 8198376
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of bone lesions in multiple myeloma and lymphoma.
Roodman GD
Cancer; 1997 Oct; 80(8 Suppl):1557-63. PubMed ID: 9362422
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of osteolytic bone destruction.
Mundy GR
Bone; 1991; 12 Suppl 1():S1-6. PubMed ID: 1954046
[TBL] [Abstract][Full Text] [Related]
5. Hypercalcemia of malignancy--new insights into an old syndrome.
Esbrit P
Clin Lab; 2001; 47(1-2):67-71. PubMed ID: 11214225
[TBL] [Abstract][Full Text] [Related]
6. Structural requirements for the action of parathyroid hormone-related protein (PTHrP) on bone resorption by isolated osteoclasts.
Evely RS; Bonomo A; Schneider HG; Moseley JM; Gallagher J; Martin TJ
J Bone Miner Res; 1991 Jan; 6(1):85-93. PubMed ID: 2048435
[TBL] [Abstract][Full Text] [Related]
7. The combined effect of tumor-produced parathyroid hormone-related protein and transforming growth factor-alpha enhance hypercalcemia in vivo and bone resorption in vitro.
Guise TA; Yoneda T; Yates AJ; Mundy GR
J Clin Endocrinol Metab; 1993 Jul; 77(1):40-5. PubMed ID: 8325957
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone-related protein in hypercalcaemia associated with haematological malignancy.
Firkin F; Seymour JF; Watson AM; Grill V; Martin TJ
Br J Haematol; 1996 Sep; 94(3):486-92. PubMed ID: 8790147
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid-hormone-related peptide in hematologic malignancies.
Kremer R; Shustik C; Tabak T; Papavasiliou V; Goltzman D
Am J Med; 1996 Apr; 100(4):406-11. PubMed ID: 8610726
[TBL] [Abstract][Full Text] [Related]
10. Significance of parathyroid hormone-related protein as a factor stimulating bone resorption and causing hypercalcemia in myeloma.
Tsujimura H; Nagamura F; Iseki T; Kanazawa S; Saisho H
Am J Hematol; 1998 Oct; 59(2):168-70. PubMed ID: 9766803
[TBL] [Abstract][Full Text] [Related]
11. [PTHrP and breast cancer].
Devys A; Lortholary A; Audran M
Bull Cancer; 2001 Nov; 88(11):1075-80. PubMed ID: 11741801
[TBL] [Abstract][Full Text] [Related]
12. Tumor resection and antibodies to parathyroid hormone-related protein cause similar changes on bone histomorphometry in hypercalcemia of cancer.
Kukreja SC; Rosol TJ; Wimbiscus SA; Shevrin DH; Grill V; Barengolts EI; Martin TJ
Endocrinology; 1990 Jul; 127(1):305-10. PubMed ID: 2361475
[TBL] [Abstract][Full Text] [Related]
13. Role of parathyroid hormone-related peptide in hypercalcemia of malignancy and the development of osteolytic metastases.
de Vernejoul MC
Rev Rhum Engl Ed; 1997 Jun; 64(6 Suppl):119S-123S. PubMed ID: 9273953
[No Abstract] [Full Text] [Related]
14. Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy.
Oyajobi BO; Anderson DM; Traianedes K; Williams PJ; Yoneda T; Mundy GR
Cancer Res; 2001 Mar; 61(6):2572-8. PubMed ID: 11289133
[TBL] [Abstract][Full Text] [Related]
15. Severe hypercalcemia in a child with acute nonlymphocytic leukemia: the role of parathyroid hormone-related protein and proinflammatory cytokines.
Kounami S; Yoshiyama M; Nakayama K; Hiramatsu C; Aoyagi N; Yoshikawa N
Acta Haematol; 2004; 112(3):160-3. PubMed ID: 15345899
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid hormone-related protein: from hypercalcemia of malignancy to developmental regulatory molecule.
Dunbar ME; Wysolmerski JJ; Broadus AE
Am J Med Sci; 1996 Dec; 312(6):287-94. PubMed ID: 8969618
[TBL] [Abstract][Full Text] [Related]
17. Hypercalcemia of cancer: an update.
Goni MH; Tolis G
Anticancer Res; 1993; 13(4):1155-60. PubMed ID: 8352538
[TBL] [Abstract][Full Text] [Related]
18. Relationship of plasma bone cytokines with hypercalcemia in cancer patients.
Motellón JL; Jiménez FJ; de Miguel F; Jaras MJ; Díaz A; Hurtado J; Esbrit P
Clin Chim Acta; 2000 Dec; 302(1-2):59-68. PubMed ID: 11074064
[TBL] [Abstract][Full Text] [Related]
19. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis.
Guise TA; Yin JJ; Taylor SD; Kumagai Y; Dallas M; Boyce BF; Yoneda T; Mundy GR
J Clin Invest; 1996 Oct; 98(7):1544-9. PubMed ID: 8833902
[TBL] [Abstract][Full Text] [Related]
20. [Serum levels of carboxyterminal propeptide of type I procollagen (PICP), cross-linked carboxyterminal telopeptide region of type I collagen (ICTP) and carboxyterminal parathyroid hormone-related protein (C-PTHrP) in hematological malignancies with bone lesions and hypercalcemia].
Tanaka K; Shiraishi K; Sakamoto A; Jojima H; Masuchi K; Okubo Y; Tanaka M; Fuzimatsu Y; Fukahori S; Osabe S; Imamura Y; Honda J; Oizumi K
Rinsho Ketsueki; 1998 Apr; 39(4):273-80. PubMed ID: 9597894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]